1. Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, Brenner DE, Steward WP, Gescher AJ, Brown K: Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 2010 Oct 1;70(19):7392-9. doi: 10.1158/0008-5472.CAN-10-2027. Epub 2010 Sep 14. [PubMed:20841478 ]
  2. Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DE: Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1246-52. [PubMed:17548692 ]
  3. Azorin-Ortuno M, Yanez-Gascon MJ, Vallejo F, Pallares FJ, Larrosa M, Lucas R, Morales JC, Tomas-Barberan FA, Garcia-Conesa MT, Espin JC: Metabolites and tissue distribution of resveratrol in the pig. Mol Nutr Food Res. 2011 Aug;55(8):1154-68. doi: 10.1002/mnfr.201100140. Epub 2011 Jun 28. [PubMed:21710561 ]
  4. Rotches-Ribalta M, Urpi-Sarda M, Llorach R, Boto-Ordonez M, Jauregui O, Chiva-Blanch G, Perez-Garcia L, Jaeger W, Guillen M, Corella D, Tinahones FJ, Estruch R, Andres-Lacueva C: Gut and microbial resveratrol metabolite profiling after moderate long-term consumption of red wine versus dealcoholized red wine in humans by an optimized ultra-high-pressure liquid chromatography tandem mass spectrometry method. J Chromatogr A. 2012 Nov 23;1265:105-13. doi: 10.1016/j.chroma.2012.09.093. Epub 2012 Oct 1. [PubMed:23089514 ]